Westfield Capital Management
http://www.westfieldcapital.com/Westfield Capital Management is an investment advisor. The firm uses a fundamental, bottom-up research oriented investment approach to uncover growth opportunities not yet fully appreciated by the market. Westfield Capital Management is based in Boston, MA.
View Older Stories View More Recent Stories
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Results; Raises Dividend to $0.12 Per Share
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Third Quarter 2017 Results
-
Vantagepoint Funds and VT PLUS Fund Are Being Made Available to Private Sector Defined Contribution Plans
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A HEXCEL CORP /DE/ Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Second Quarter 2017 Results
-
Randy Watts Joins O'Neil as Chief Investment Strategist
-
Boston Private Financial Holdings, Inc. Reports First Quarter 2017 Results
-
Form SC 13G/A Huron Consulting Group Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A MERRIMACK PHARMACEUTICAL Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A ARIAD PHARMACEUTICALS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A MERRIMACK PHARMACEUTICAL Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A RUSH ENTERPRISES INC Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A ARIAD PHARMACEUTICALS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A XPO Logistics, Inc. Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A SUPERIOR ENERGY SERVICES Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A AMAG PHARMACEUTICALS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Fourth Quarter and Full Year 2016 Results; Raises Dividend to $0.11 Per Share
-
Boston Private Financial Holdings, Inc. Reports Third Quarter 2016 Results
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Second Quarter 2016 Results
-
Boston Private Financial Holdings, Inc. Reports First Quarter 2016 Results
-
Form SC 13G/A Wright Medical Group Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G RUSH ENTERPRISES INC Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G PTC THERAPEUTICS, INC. Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G MERRIMACK PHARMACEUTICAL Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G ARIAD PHARMACEUTICALS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G AMAG PHARMACEUTICALS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A MWI Veterinary Supply, Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Aegerion Pharmaceuticals Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Fourth Quarter and Year End 2015 Results; Raises Dividend to $0.10 Per Share
-
SevOne Appoints Rafe Brown as Chief Financial Officer
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Third Quarter 2015 GAAP EPS of $0.16
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
SevOne Announces $50 Million Financing Round Led by Westfield Capital Management and Bain Capital Ventures
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports Second Quarter 2015 GAAP EPS of $0.20
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Boston Private Financial Holdings, Inc. Reports First Quarter 2015 GAAP EPS of $0.21
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
-
Form SC 13G/A Cardiome Pharma Corp Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP

